These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29509010)

  • 1. Insight into the Electrochemical Reduction Mechanism of Pt(IV) Anticancer Complexes.
    Tolbatov I; Coletti C; Marrone A; Re N
    Inorg Chem; 2018 Mar; 57(6):3411-3419. PubMed ID: 29509010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding intrinsically irreversible, non-Nernstian, two-electron redox processes: a combined experimental and computational study of the electrochemical activation of platinum(IV) antitumor prodrugs.
    McCormick MC; Keijzer K; Polavarapu A; Schultz FA; Baik MH
    J Am Chem Soc; 2014 Jun; 136(25):8992-9000. PubMed ID: 24853204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantum chemical modeling of the reduction of cis-diammineplatinum(IV) tetrachloride [Pt(NH3)2Cl4] by methyl thiolate anion.
    Dobrogorskaia-Méreau IaI; Nemukhin AV
    J Comput Chem; 2005 Jul; 26(9):865-70. PubMed ID: 15825188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics and mechanism for reduction of the anticancer prodrug trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)] (JM335) by thiols.
    Lemma K; Shi T; Elding LI
    Inorg Chem; 2000 Apr; 39(8):1728-34. PubMed ID: 12526561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione.
    Lemma K; Berglund J; Farrell N; Elding LI
    J Biol Inorg Chem; 2000 Jun; 5(3):300-6. PubMed ID: 10907740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on electronic properties, thermodynamic and kinetic parameters of the selected platinum(II) derivatives interacting with guanine.
    Šebesta F; Burda JV
    J Inorg Biochem; 2017 Jul; 172():100-109. PubMed ID: 28448876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction Process of Tetraplatin in the Presence of Deoxyguanosine Monophosphate (dGMP): A Computational DFT Study.
    Šebesta F; Burda JV
    Chemistry; 2016 Jan; 22(3):1037-47. PubMed ID: 26663432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of 3,6-dioxa-1,8-octanedithiol by platinum(IV) anticancer prodrug and model complex: kinetic and mechanistic studies.
    Huo S; Shen S; Liu D; Shi T
    J Phys Chem B; 2012 Jun; 116(22):6522-8. PubMed ID: 22574871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes.
    Jin S; Hao Y; Zhu Z; Muhammad N; Zhang Z; Wang K; Guo Y; Guo Z; Wang X
    Inorg Chem; 2018 Sep; 57(17):11135-11145. PubMed ID: 30117731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-platinum interactions in vitro with trans- and cis-Pt(NH3)2Cl2.
    Macquet JP; Theophanides T
    Bioinorg Chem; 1975; 5(1):59-66. PubMed ID: 1182209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinterpretation of the vibrational spectroscopy of the medicinal bioinorganic synthon c,c,t-[Pt(NH3)2Cl2(OH)2].
    Johnstone TC; Lippard SJ
    J Biol Inorg Chem; 2014 Jun; 19(4-5):667-74. PubMed ID: 24515615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-selenomethionine reduces platinum(IV) anticancer model compounds at strikingly faster rates than L-methionine.
    Huo S; Dong J; Shen S; Ren Y; Song C; Xu J; Shi T
    Dalton Trans; 2014 Nov; 43(41):15328-36. PubMed ID: 25075569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Satraplatin be hydrated before the reduction process occurs? The DFT computational study.
    Bradáč O; Zimmermann T; Burda JV
    J Mol Model; 2013 Nov; 19(11):4669-80. PubMed ID: 22643969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insight into protonolysis and cis-trans isomerization of benzylplatinum(II) complexes assisted by weak ligand-to-metal interactions. A combined kinetic and DFT study.
    Guido E; D'Amico G; Russo N; Sicilia E; Rizzato S; Albinati A; Romeo A; Plutino MR; Romeo R
    Inorg Chem; 2011 Mar; 50(6):2224-39. PubMed ID: 21341750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical investigation into the mechanism of 3'-dGMP oxidation by [Pt(IV)Cl4(dach)].
    Ariafard A; Ghohe NM; Abbasi KK; Canty AJ; Yates BF
    Inorg Chem; 2013 Jan; 52(2):707-17. PubMed ID: 23270414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases.
    Zhou L
    J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor Platinium(IV) Prodrugs: A Systematic Computational Exploration of Their Reduction Mechanism by l-Ascorbic Acid.
    Dabbish E; Ponte F; Russo N; Sicilia E
    Inorg Chem; 2019 Mar; 58(6):3851-3860. PubMed ID: 30843385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and mechanism of reactions of the drug tiopronin with platinum(IV) complexes.
    Huo S; Shi H; Liu D; Shen S; Zhang J; Song C; Shi T
    J Inorg Biochem; 2013 Aug; 125():9-15. PubMed ID: 23665090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.